Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: 6 trading days left in the quarter after today

You and I are in exact agreement re: expectations on the 10Q.

"I will be surprised if we see anything less than $60M in revenue (our portion) and any legal expense exceeding $5M. Just a guess, hoping for more.....revenue that is."

And I think it's better than a guess.  Those relying on old numbers to extrapolate current numbers are being completely unrealistic IMO.  Averaging in the numbers from pre-Markman and pre-settlement with the Js have no relevance to more recent signings - especially the licenses with the Js.  Thus, IMO, using the old numbers only suggests absolute minimums (sub-minimums).

I could again point to the more relevant numbers (e.g., how much did Fujitsu pay?  $32M, from a company with lower output than the remaining Js), but it's my same ole song and dance.  But it does back up our shared expectations.

JMHO,

SGE

Share
New Message
Please login to post a reply